| Alan S Oster, MD | |
|
160 London Mountain View Dr, London, KY 40741-6601 | |
| (606) 864-0770 | |
| (606) 864-1461 |
| Full Name | Alan S Oster |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 25 Years |
| Location | 160 London Mountain View Dr, London, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598792780 | NPI | - | NPPES |
| 64130362 | Medicaid | KY | |
| P00427867 | Other | KY | RAILROAD MCR - NOTC |
| 200871410 | Medicaid | IN | |
| 000000486615 | Other | KY | ANTHEM - NOTC |
| 000023027E | Other | KY | HUMANA - NOTC |
| 4654691 | Other | KY | CIGNA - NOTC |
| 077849 | Other | KY | SIHO - NOTC |
| 2807605000 | Other | KY | PASSPORT ADVANTAGE - NOTC |
| 50013605 | Other | KY | PASSPORT - NOTC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 39540 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Caretenders | Lexington, KY | Home health agency |
| Nurse On Call | Lexington, KY | Home health agency |
| Frankfort Regional Medical Center | Frankfort, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Proactive Therapy, Inc | 0143245415 | 58 |
| Commonwealth Specialists Of Kentucky Llc | 2466519673 | 10 |
News Archive
Canopus BioPharma, Inc. has announced that the South African Medicines Control Council has granted approval for a Phase II study in 30 cancer patients evaluating the protective effect of CB1400 on the gastrointestional tract from radiation-induced mucositis. This new trial is an important step forward in the development of CB1400 as a novel, preventative, anti-mucositis agent.
Two previously unrecognized genetic markers may predict whether breast cancer patients would benefit from chemotherapy followed by tamoxifen, according to preclinical research from Roswell Park Cancer Institute, in collaboration with the cooperative research group SWOG and St. Jude Children's Research Hospital. The results of this research will be presented at the American Association for Cancer Research Annual Meeting 2016, to be held April 16-20 in New Orleans.
Titan Pharmaceuticals, Inc. (Pink Sheets: TTNP) today announced that on January 14, 2010 it filed a registration statement on Form 10 with the U.S. Securities and Exchange Commission ("SEC") in order to register its common stock under the Securities Exchange Act of 1934 ("Exchange Act").
Memphis-based Computable Genomix today announced that the National Institutes of Health Library has purchased a subscription to its premier product, GeneIndexer, an online genomics research tool.
› Verified 9 days ago
| Entity Name | Commonwealth Specialists Of Kentucky Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770741498 PECOS PAC ID: 2466519673 Enrollment ID: O20090314000022 |
News Archive
Canopus BioPharma, Inc. has announced that the South African Medicines Control Council has granted approval for a Phase II study in 30 cancer patients evaluating the protective effect of CB1400 on the gastrointestional tract from radiation-induced mucositis. This new trial is an important step forward in the development of CB1400 as a novel, preventative, anti-mucositis agent.
Two previously unrecognized genetic markers may predict whether breast cancer patients would benefit from chemotherapy followed by tamoxifen, according to preclinical research from Roswell Park Cancer Institute, in collaboration with the cooperative research group SWOG and St. Jude Children's Research Hospital. The results of this research will be presented at the American Association for Cancer Research Annual Meeting 2016, to be held April 16-20 in New Orleans.
Titan Pharmaceuticals, Inc. (Pink Sheets: TTNP) today announced that on January 14, 2010 it filed a registration statement on Form 10 with the U.S. Securities and Exchange Commission ("SEC") in order to register its common stock under the Securities Exchange Act of 1934 ("Exchange Act").
Memphis-based Computable Genomix today announced that the National Institutes of Health Library has purchased a subscription to its premier product, GeneIndexer, an online genomics research tool.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alan S Oster, MD Po Box 936, London, KY 40743-0936 Ph: (606) 330-7840 | Alan S Oster, MD 160 London Mountain View Dr, London, KY 40741-6601 Ph: (606) 864-0770 |
News Archive
Canopus BioPharma, Inc. has announced that the South African Medicines Control Council has granted approval for a Phase II study in 30 cancer patients evaluating the protective effect of CB1400 on the gastrointestional tract from radiation-induced mucositis. This new trial is an important step forward in the development of CB1400 as a novel, preventative, anti-mucositis agent.
Two previously unrecognized genetic markers may predict whether breast cancer patients would benefit from chemotherapy followed by tamoxifen, according to preclinical research from Roswell Park Cancer Institute, in collaboration with the cooperative research group SWOG and St. Jude Children's Research Hospital. The results of this research will be presented at the American Association for Cancer Research Annual Meeting 2016, to be held April 16-20 in New Orleans.
Titan Pharmaceuticals, Inc. (Pink Sheets: TTNP) today announced that on January 14, 2010 it filed a registration statement on Form 10 with the U.S. Securities and Exchange Commission ("SEC") in order to register its common stock under the Securities Exchange Act of 1934 ("Exchange Act").
Memphis-based Computable Genomix today announced that the National Institutes of Health Library has purchased a subscription to its premier product, GeneIndexer, an online genomics research tool.
› Verified 9 days ago
Dr. Adam Kimball Franson, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 London Mountain View Dr, London, KY 40741 Phone: 606-864-0770 Fax: 606-864-1461 | |
Dr. Vincent Angelo Depalma, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 London Mountain View Dr, London, KY 40741 Phone: 606-864-0770 Fax: 606-864-1461 | |
Jean Maurice Page', M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 London Mountain View Dr, London, KY 40741 Phone: 606-864-0770 Fax: 606-864-1461 | |
Patrice Beliveau, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 London Mountain View Dr, London, KY 40741 Phone: 606-864-0770 Fax: 606-864-1461 | |
Kevin Michael Magone, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 160 London Mountain View Dr, London, KY 40741 Phone: 606-864-0770 Fax: 606-864-1461 |